We are live on ! Find out more
IOVA icon

Iovance Biotherapeutics
IOVA

228 hedge funds and large institutions have $1.25B invested in Iovance Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 65 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

38% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 29

34% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 65

15% more capital invested

Capital invested by funds: $1.1B → $1.25B (+$159M)

12% more call options, than puts

Call options by funds: $6.36M | Put options by funds: $5.67M

5% more funds holding

Funds holding: 218 → 228 (+10)

18.12% less ownership

Funds ownership: 109.66% → 91.54% (-18%)

Holders
228
Holders Change
+10
Holders Change %
+4.59%
% of All Funds
3.63%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
40
Increased
87
Reduced
65
Closed
29
Calls
$6.36M
Puts
$5.67M
Net Calls
+$682K
Net Calls Change
-$4.6M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$60.7M
2
PA
Perceptive Advisors
New York
+$37M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$18.8M
4
Morgan Stanley
Morgan Stanley
New York
+$18.8M
5
O
OrbiMed
New York
+$18.6M

Top Sellers

1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$12.8M
2
FC
Finepoint Capital
Massachusetts
-$9.88M
3
Renaissance Technologies
Renaissance Technologies
New York
-$9.14M
4
Ameriprise
Ameriprise
Minnesota
-$8.06M
5
State Street
State Street
Massachusetts
-$6.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$93.7M +$37M +5,367,955 +54%
State Street
2
State Street
Massachusetts
$83.9M -$6.78M -982,442 -7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$82.7M -$6.37M -922,953 -6%
BlackRock
4
BlackRock
New York
$76.1M +$2.62M +379,560 +3%
MFM
5
MHR Fund Management
New York
$73.3M – – –
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$53.8M +$60.7M +8,800,059 New
Morgan Stanley
7
Morgan Stanley
New York
$47M +$18.8M +2,722,822 +55%
ACA
8
Avoro Capital Advisors
New York
$42.9M – – –
O
9
OrbiMed
New York
$28.8M +$18.6M +2,700,000 +134%
Goldman Sachs
10
Goldman Sachs
New York
$24M +$2M +289,919 +8%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$22.9M -$641K -92,863 -2%
BC
12
Boxer Capital
California
$22.6M +$15.2M +2,200,000 +146%
Artisan Partners
13
Artisan Partners
Wisconsin
$21.8M +$5.75M +832,974 +30%
Citadel Advisors
14
Citadel Advisors
Florida
$21.2M +$8.13M +1,177,989 +51%
Millennium Management
15
Millennium Management
New York
$20.9M +$15.4M +2,229,060 +188%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$18.6M +$1.61M +233,052 +8%
Balyasny Asset Management
17
Balyasny Asset Management
Illinois
$16.7M +$18.8M +2,731,832 +72,771%
Franklin Resources
18
Franklin Resources
California
$16.5M -$4.13M -599,239 -18%
CS
19
Credit Suisse
Switzerland
$16.5M +$216K +31,262 +1%
MB
20
MPM BioImpact
Massachusetts
$16M +$3.21M +465,427 +22%
Sumitomo Mitsui Trust Group
21
Sumitomo Mitsui Trust Group
Japan
$15.7M -$100K -14,527 -0.6%
Two Sigma Investments
22
Two Sigma Investments
New York
$15.6M +$11.5M +1,663,254 +186%
NAMA
23
Nikko Asset Management Americas
New York
$15.4M -$267K -38,627 -1%
Norges Bank
24
Norges Bank
Norway
$14.9M -$3.69M -534,800 -18%
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$14.4M -$12.8M -1,861,809 -44%
1
2 3 4 5